03280nam a22004695i 4500001001800000003000900018005001700027007001500044008004100059020003700100024003500137050001200172072001600184072002300200072001500223245014200238250001800380264007500398300006400473336002600537337002600563338003600589347002400625505057200649520109701221650002402318650002902342650002302371650002402394650002802418650002302446700008202469710003402551773002602585776003602611776003602647776003602683856004602719912001402765912001402779999001702793978-3-031-66590-5DE-He21320251030113057.0cr nn 008mamaa240921s2024    sz |    s    |||| 0|eng d  a97830316659059978-3-031-66590-57 a10.1007/978-3-031-66590-52doi 4aRL1-803 7aMJK2bicssc 7aMED0170002bisacsh 7aMJK2thema10aImmunomodulators and Biologics in Dermatologic Treatmenth[electronic resource] :bTurning Theory into Practice /cedited by Neal Bhatia.  a1st ed. 2024. 1aCham :bSpringer International Publishing :bImprint: Springer,c2024.  aVI, 184 p. 22 illus., 14 illus. in color.bonline resource.  atextbtxt2rdacontent  acomputerbc2rdamedia  aonline resourcebcr2rdacarrier  atext filebPDF2rda0 aIntroduction -- Mechanisms of Action: Targets for Immunomodulators -- Steroid and Non-Steroid Immunomodulators -- Biologics as Immunomodulators -- Combinations of topical and systemic Immunomodulators,- Nanotechnology and Immunomodulators -- Antibiotics and Antimicrobials as Immunomodulators -- Integrative Therapies as Immunomodulators -- Immunomodulators and Biologics for Follicular and Neutrophilic Cutaneous Disorders -- Immunomodulators for Common Dermatologic Disorders -- Prescribing and Advocating for Immunomodulators in Dermatology Practice -- Conclusion.  aThis title provides a practically applicable guide to the use of immunomodulators and biologics to treat cutaneous diseases. Chapters cover the mechanisms, applications and safety concerns pertaining to the latest systemic therapies. Extensive guidance is provided on how to design lab monitoring schedules, manage patient follow-up visits, develop tapering plans and assess adverse outcomes. The book also reviews how to initiate off-label applications and establish methods of matching mechanisms for a range of diseases to the mechanisms of the available therapies. The latest updates in the development and utility of systemic immunomodulators, biologics and JAK Inhibitors from clinical trials and updated guidelines are also discussed. Immunomodulators and Biologics in Dermatologic Treatment comprehensively describes the use of a range of systemic therapies for immunomodulation in dermatology and how best to incorporate these into practice. It therefore represents a valuable resource for novice readers and experienced dermatologists involved in the management of these patients. . 0aDermatology.972926 0aMedical sciences.965984 0aInternal medicine.14aDermatology.97292624aHealth Sciences.96598724aInternal Medicine.1 aBhatia, Neal.eeditor.4edt4http://id.loc.gov/vocabulary/relators/edt9847782 aSpringerLink (Online service)0 tSpringer Nature eBook08iPrinted edition:z978303166589908iPrinted edition:z978303166591208iPrinted edition:z978303166592940uhttps://doi.org/10.1007/978-3-031-66590-5  aZDB-2-SME  aZDB-2-SXM  c63598d63598